DLAT and renal carcinoma: In vitro experiments showed that the expression of DLAT in normal renal cells (HK-2) was significantly higher than that in renal cancer cells (OS-RC-2 and 786-O), regardless of the mRNA or protein expression (Figures 6A, 6B).